MyFinsight
Home
Blog
About
Short-term investments
$313,056K
(187.09%↑ Y/Y)
Accounts receivable
$37,494K
(1906.10%↑ Y/Y)
Cash and cash
equivalents
$17,224K
(-64.88%↓ Y/Y)
Prepaid expenses and
other current assets
$4,464K
(-4.31%↓ Y/Y)
Restricted cash
$917K
(-10.80%↓ Y/Y)
Total current assets
$373,155K
(126.68%↑ Y/Y)
Operating lease
right-of-use asset
$5,037K
(-15.30%↓ Y/Y)
Property and equipment,
net
$1,079K
(-44.55%↓ Y/Y)
Goodwill
$949K
(0.00%↑ Y/Y)
Restricted cash
$610K
(-40.66%↓ Y/Y)
Intangible assets, net
$365K
(-28.43%↓ Y/Y)
Other assets
$31K
(-44.64%↓ Y/Y)
Total assets
$381,226K
(117.77%↑ Y/Y)
Total liabilities and
stockholders' equity
$381,226K
(117.77%↑ Y/Y)
Total stockholders'
equity
$302,068K
(151.91%↑ Y/Y)
Total liabilities
$79,158K
(43.54%↑ Y/Y)
Accumulated deficit
-$750,863K
(-12.37%↓ Y/Y)
Accumulated other
comprehensive income
-$196K
(-693.94%↓ Y/Y)
Additional paid-in capital
$1,053,125K
(33.63%↑ Y/Y)
Total current
liabilities
$39,861K
(1.63%↑ Y/Y)
Deferred revenue, net of
current portion
$30,617K
(198.96%↑ Y/Y)
Other long-term
liabilities
$4,472K
(5.45%↑ Y/Y)
Operating lease
liabilities - long term
$4,208K
(191.82%↑ Y/Y)
Common stock
$2K
(0.00%↑ Y/Y)
Deferred revenue,
current portion
$24,073K
(9.17%↑ Y/Y)
Accrued liabilities
$12,353K
(7.39%↑ Y/Y)
Accounts payable
$1,939K
(754.19%↑ Y/Y)
Operating lease
liabilities - short term
$1,496K
(-72.52%↓ Y/Y)
Back
Back
Balance Sheet
CytomX Therapeutics, Inc. (CTMX)
CytomX Therapeutics, Inc. (CTMX)
source: myfinsight.com